Drug Shortage Report for ACH-ESCITALOPRAM
| Report ID | 177036 |
| Drug Identification Number | 02434660 |
| Brand name | ACH-ESCITALOPRAM |
| Common or Proper name | ESCITALOPRAM |
| Company Name | ACCORD HEALTHCARE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ESCITALOPRAM |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | N06AB |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2022-12-02 |
| Estimated end date | |
| Actual end date | 2023-10-05 |
| Shortage status | Resolved |
| Updated date | 2023-10-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.